QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 strata-skin-sciences-publishes-clinical-case-study-on-308-nm-excimer-laser-use-in-rare-pmf-subtype-of-cutaneous-t-cell-lymphoma

First English-language case study shows resolution of lesions with 308-nm Excimer laser in rare mycosis fungoides (MF) subtype,...

 strata-skins-treatment-for-plaque-type-psoriasis-enhances-outcomes-compared-to-topical-monotherapy-study-demonstrates

HORSHAM, Pa., Sept. 30, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ...

Core News & Articles

Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The m...

 strata-skin-sciences-highlights-peer-reviewed-study-showing-superior-efficacy-of-308nm-excimer-laser-in-combination-with-oral-jak-inhibitor-in-vitiligo-treatment

STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to...

 strata-skin-sciences-reports-growth-in-partner-clinics-using-elevate-360-platform

STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION